Antiviral Drug Development: Innovations and Applications
Shaping the Future of Public Health: Innovate in Antiviral Drug Development
Early access to e-LMS included
About This Course
Antiviral Drug Development: Innovations and Applications is an intensive program designed to introduce participants to the dynamic field of antiviral research and pharmaceutical development. This program will cover fundamental virology, the mechanisms of viral entry and replication, and the current landscape of antiviral therapies including small molecule drugs, vaccines, and novel therapeutic strategies such as RNA interference and CRISPR-based treatments.
Aim
This program aims to equip participants with cutting-edge knowledge and practical skills necessary for the development and application of antiviral drugs. It focuses on the latest research, innovation in drug design, and the application of these drugs in managing and treating viral infections effectively.
Program Objectives
- Explore the diverse range of viruses and their impact on human health.
- Gain insights into the drug discovery process for antiviral therapies.
- Understand the mechanisms of action of different antiviral drugs.
- Analyze the challenges associated with antiviral drug resistance.
- Discuss the latest innovations in antiviral drug development, including gene editing and RNA interference
Program Structure
Week 1: Virology and Drug Discovery Fundamentals
-
Viral replication cycles and molecular targets
-
Host-virus interactions and immune evasion mechanisms
-
Antiviral drug classifications and mechanisms of action
-
Historical milestones in antiviral therapeutics
Week 2: Drug Design Strategies and Screening Technologies
-
Rational drug design and structure-based approaches
-
High-throughput screening and compound libraries
-
In vitro antiviral assays and viral inhibition metrics
-
Computational modeling and AI-assisted drug prediction
Week 3: Therapeutic Innovation and Delivery Systems
-
Nucleoside analogues, protease inhibitors, and fusion blockers
-
Nanotechnology and targeted delivery platforms
-
Drug resistance and viral mutation management
-
Repurposing drugs for emerging viral infections
Week 4: Translational Research, Trials, and Regulatory Pathways
-
Clinical development pipeline and trial design
-
Regulatory compliance (FDA, EMA, CDSCO)
-
Emergency use authorization and pandemic preparedness
-
Future directions: mRNA antivirals, AI-driven formulation, global access
Who Should Enrol?
-
Students & Postgraduates in Virology, Pharmaceutical Sciences, Biotechnology, or Molecular Biology
-
PhD Scholars & Researchers involved in drug development, virology, or host-pathogen biology
-
Professionals in pharma R&D, biotech innovation, or regulatory affairs
-
Health Tech Entrepreneurs & Scientists exploring AI, nanotech, or bioinformatics in antiviral therapy
Program Outcomes
- Acquire the knowledge and skills to critically evaluate current and future antiviral drugs.
- Develop an understanding of the regulatory processes involved in bringing new antiviral therapies to market.
- Gain insights into potential career paths within the antiviral drug development industry.
- Stay informed about the latest advancements in antiviral research.
Fee Structure
Standard: ₹8,998 | $198
Discounted: ₹4499 | $99
We accept 20+ global currencies. View list →
What You’ll Gain
- Full access to e-LMS
- Real-world dry lab projects
- 1:1 project guidance
- Publication opportunity
- Self-assessment & final exam
- e-Certificate & e-Marksheet
Join Our Hall of Fame!
Take your research to the next level with NanoSchool.
Publication Opportunity
Get published in a prestigious open-access journal.
Centre of Excellence
Become part of an elite research community.
Networking & Learning
Connect with global researchers and mentors.
Global Recognition
Worth ₹20,000 / $1,000 in academic value.
View All Feedbacks →